Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard A Fine

Showing results (61-70 of 168) with videos related to

Pageof 17
Sort By:
Blood|August 28, 2004
Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma modelStasia A Anderson, John Glod, Ali S Arbab, et al.
Cancer Research|March 6, 2023
Microenvironment-Driven Dynamic Chromatin Changes in Glioblastoma Recapitulate Early Neural Development at Single-Cell ResolutionAllison R Pine, Stefano M Cirigliano, Richa Singhania, et al.
Advances in Radiation Oncology|September 10, 2024
Positron Emission Tomography and Magnetic Resonance Imaging Findings in the Diagnosis of Stroke-Like Migraine Attacks after Radiation Therapy Syndrome: A Case ReportSteven D Pan, Joseph R Osborne, Gloria C Chiang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 5, 2005
Evaluation of (76)Br-FBAU as a PET reporter probe for HSV1-tk gene expression imaging using mouse models of human gliomaSteve Y Cho, Laura Ravasi, Lawrence P Szajek, et al.
CNS Oncology|February 11, 2016
A Phase II trial of tandutinib (MLN 518) in combination with bevacizumab for patients with recurrent glioblastomaYazmin Odia, Joohee Sul, Joanna H Shih, et al.
Neoplasia (New York, N.Y.)|March 6, 2008
FK506 binding protein mediates glioma cell growth and sensitivity to rapamycin treatment by regulating NF-kappaB signaling pathwayWei Jiang, Simona Cazacu, Cunli Xiang, et al.
Cancer|February 10, 2010
Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomasFabio M Iwamoto, Teri N Kreisl, Lyndon Kim, et al.
Journal of Biomedical Informatics|September 11, 2010
Gene pathways and subnetworks distinguish between major glioma subtypes and elucidate potential underlying biologyStefan Wuchty, Alice Zhang, Jennifer Walling, et al.
Neuro-Oncology|February 13, 2010
A phase I/II trial of enzastaurin in patients with recurrent high-grade gliomasTeri N Kreisl, Svetlana Kotliarova, John A Butman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trialStuart A Grossman, Xiaobu Ye, Marc Chamberlain, et al.
Pageof 17

Showing results (61-70 of 168) with videos related to

Sort By:
Pageof 17
Blood|August 28, 2004
Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma modelStasia A Anderson, John Glod, Ali S Arbab, et al.
Cancer Research|March 6, 2023
Microenvironment-Driven Dynamic Chromatin Changes in Glioblastoma Recapitulate Early Neural Development at Single-Cell ResolutionAllison R Pine, Stefano M Cirigliano, Richa Singhania, et al.
Advances in Radiation Oncology|September 10, 2024
Positron Emission Tomography and Magnetic Resonance Imaging Findings in the Diagnosis of Stroke-Like Migraine Attacks after Radiation Therapy Syndrome: A Case ReportSteven D Pan, Joseph R Osborne, Gloria C Chiang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 5, 2005
Evaluation of (76)Br-FBAU as a PET reporter probe for HSV1-tk gene expression imaging using mouse models of human gliomaSteve Y Cho, Laura Ravasi, Lawrence P Szajek, et al.
CNS Oncology|February 11, 2016
A Phase II trial of tandutinib (MLN 518) in combination with bevacizumab for patients with recurrent glioblastomaYazmin Odia, Joohee Sul, Joanna H Shih, et al.
Neoplasia (New York, N.Y.)|March 6, 2008
FK506 binding protein mediates glioma cell growth and sensitivity to rapamycin treatment by regulating NF-kappaB signaling pathwayWei Jiang, Simona Cazacu, Cunli Xiang, et al.
Cancer|February 10, 2010
Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomasFabio M Iwamoto, Teri N Kreisl, Lyndon Kim, et al.
Journal of Biomedical Informatics|September 11, 2010
Gene pathways and subnetworks distinguish between major glioma subtypes and elucidate potential underlying biologyStefan Wuchty, Alice Zhang, Jennifer Walling, et al.
Neuro-Oncology|February 13, 2010
A phase I/II trial of enzastaurin in patients with recurrent high-grade gliomasTeri N Kreisl, Svetlana Kotliarova, John A Butman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trialStuart A Grossman, Xiaobu Ye, Marc Chamberlain, et al.
Pageof 17